An official website of the United States government

This repository is under review for potential modification in compliance with Administration directives.

Publication Information

PubMed ID
Public Release Type
Journal
Publication Year
2022
Affiliation
Division of Gastroenterology, Texas Tech University Health Sciences Center, El Paso, Texas. Electronic address: irene.sarosiek@ttuhsc.edu.; Data Coordinating Center, Johns Hopkins University, Baltimore, Maryland.; Section of Gastroenterology, Temple University, Philadelphia, Pennsylvania.; Division of Gastroenterology, University of Louisville, Louisville, Kentucky.; Section on Gastroenterology, Wake Forest University, Winston Salem, North Carolina.; Massachusetts General Hospital, Digestive Health Center, Boston, Massachusetts.; Baylor College of Medicine Children's Nutrition Research Center, Houston, Texas.; Section of Gastroenterology, Mayo Clinic, Jacksonville, Florida.; Section of Gastroenterology, Mayo Clinic, Rochester, Minnesota.; National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland.; Division of Gastroenterology, Johns Hopkins University, Baltimore, Maryland.; Data Coordinating Center, Johns Hopkins University, Baltimore, Maryland.; Data Coordinating Center, Johns Hopkins University, Baltimore, Maryland.; Data Coordinating Center, Johns Hopkins University, Baltimore, Maryland.; Data Coordinating Center, Johns Hopkins University, Baltimore, Maryland.; Data Coordinating Center, Johns Hopkins University, Baltimore, Maryland.; Division of Gastroenterology, Texas Tech University Health Sciences Center, El Paso, Texas.
Authors
Sarosiek Irene, Van Natta Mark, Parkman Henry P, Abell Thomas, Koch Kenneth L, Kuo Braden, Shulman Robert J, Farrugia Gianrico, Grover Madhusudan, Hamilton Frank A, Pasricha Pankaj J, Yates Katherine P, Miriel Laura, Wilson Laura, Yamada Goro, Tonascia James, McCallum Richard W
Studies

Abstract

The use of domperidone (DOM) for gastroparesis (GP) remains controversial and limited. We aimed to present outcomes of DOM therapy for treatment of patients participating in the multicenter National Institute of Diabetes and Digestive and Kidney Diseases Gastroparesis Clinical Research Consortium (GpCRC) Registries (GpR).